Clinical / Surgical: Paradigm changing clinical trials in cardiometabolic disease
Tracks
Clinical/Surgical
Friday, August 15, 2025 |
1:45 PM - 3:15 PM |
Speaker
A/Prof Priya Sumithran
A/Prof
Monash University
GLP-1 agonists and cardiovascular risk reduction in obese and overweight patients
1:45 PM - 2:05 PMBiography
Associate Professor Priya Sumithran is an endocrinologist and researcher. She is clinical lead of Obesity Medicine at Alfred Health and leads the Obesity and Metabolic Medicine group at the School of Translational Medicine, Monash University. Her work focuses on the care of people with obesity and related diseases.
Prof John McMurray
Professor of Cardiology
University of Glasgow
SGLT-2 inhibitors and cardiovascular risk reduction
2:05 PM - 2:25 PMBiography
Professor McMurray is currently Professor of Medical Cardiology and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow.
Professor McMurray served as the inaugural Eugene Braunwald Scholar in Cardiovascular Disease at the Brigham and Women’s Hospital, Boston, and visiting Professor of Medicine, Harvard University, Boston, Massachusetts USA 2010/2011. He is a Past-President of the Heart Failure Association of the ESC.
He is a Highly Cited Researcher and has a H-index of >200. He is and has been involved in many guideline committees, including chairing the Task Force for 2012 ESC Guidelines on heart failure and was a member of the 2016 and 2021 Task Forces. Professor McMurray is an Associate Editor for JACC-Heart Failure and is also a member of the editorial board of several journals including the European Journal of Heart Failure, Diabetes Care and the New England Journal of Medicine, and Guest Editor for Circulation & Circulation: Heart Failure. He is the Congress Programme Committee Chair for the European Society of Cardiology 2023/2024 and European Society of Cardiology Board Member.
Professor McMurray was a member of the recent European Society of Cardiology (ESC) Task Force that created a policy on gender and the NEJM policy group on diversity in research studies.
He has won several awards, including the Stokes Medal of the Irish Cardiac Society. In June 2015, Professor John McMurray and Professor Salim Yusuf (McMaster University, Hamilton Ontario, Canada) were jointly awarded the 8th Arrigo Recordati International Prize for Scientific Research (for outstanding contributions in secondary prevention and risk reduction strategies in patients with cardiovascular diseases).
Professor McMurray is the recipient of the Mackenzie Medal, which is awarded by the British Cardiovascular Society in recognition of outstanding service to British Cardiology. He is also the recipient of the Louis and Artur Lucian Award for Research in Circulatory Diseases, which is awarded each year by McGill University, Montreal. This international award recognises outstanding research in the field of circulatory diseases by a scientific investigator, or group of investigators, whose contribution to knowledge in this field is deemed worthy of special recognition.
Professor McMurray was awarded an (honorary) OBE in 2019 by Her Majesty the Queen, in recognition of his services to cardiovascular research. In 2020 he was awarded the Gold Medal of the European Society of Cardiology, which the society describes as “the highest honour it can bestow on exceptional scientists for their contribution to cardiovascular medicine”. In 2021 Professor McMurray received the Rigshospitalet’s International KFJ Award. In 2023 he was made an honorary fellow of the Japanese Circulation Society. Professor McMurray has been invited to lecture widely at many international congresses and delivered many several named lectures.
Assoc Prof Brendon Neuen
Nephrologist
The George Institute for Global Health
Novel cardiometabolic agents for prevention of progression of kidney disease
2:25 PM - 2:45 PMBiography
Associate Professor Brendon Neuen is a Nephrologist and Director of Kidney Trials at Royal North Shore Hospital and Senior Fellow at The George Institute for Global Health. He completed training in nephrology and clinical trials in Sydney, Oxford, and Boston. Widely recognized for his expertise in cardio-kidney-metabolic medicine, he serves on the executive committees of multiple international trials evaluating new therapeutic strategies to reduce cardio-renal risk. He also co-chairs the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium, pooling data from over 90,000 participants. His work has been cited more than 25 international guidelines and scientific statements.
Prof Peter Toth
Director of Research Service Facility - Cellular Imaging
University of Illinois at Chicago
Managing dyslipidemia in patients with chronic kidney disease
2:45 PM - 3:05 PMBiography
Peter P. Toth, MD, PhD is Director of Preventive Cardiology at the CGH Medical Center in Sterling, Illinois, USA. He is Professor of Clinical Family and Community Medicine at the University of Illinois School of Medicine and Adjunct Professor of Medicine at the Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine. Dr. Toth is a past president of the National Lipid Association, the American Board of Clinical Lipidology, and the American Society for Preventive Cardiology. He is the immediate past chair of the American Heart Association’s Council on Lipids, Lipoproteins, and Thrombosis and is a member of the American College of Cardiology’s Board of Councilors. Dr. Toth has authored and co-authored over 500 publications in medical and scientific journals and textbooks. He is Series Editor of Springer’s textbook collection in Contemporary Cardiology. He has edited and written 23 textbooks on various aspects of cardiovascular medicine. He has lectured on many topics in cardiovascular medicine throughout the world.
All speakers
Panel discussion: Practical considerations in initiating GLP-1 therapy
3:00 PM - 3:15 PMBiography
Prof Anthony Keech
Doctor
University of Sydney / Royal Prince Alfred Hospital
Chairperson
Biography
Prof Stephen Nicholls
Director
Victorian Heart Hospital
Chairperson
Biography
MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS
Director of Victorian Heart Hospital, MonashHeart & ICU, Monash Health
Director of Victorian Heart Institute, Monash University
Professor of Cardiology, Monash University
Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the inaugural Director of the Victorian Heart Hospital which opened in February 2023.
Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations.
His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease.
He is Chair of the Asia Pacific Cardiometabolic Consortium, past-President of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.
